BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34671112)

  • 1. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
    Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
    Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
    Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
    Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic profile of a central European urban random population-Czech population.
    Proietti R; Maranho Neto GA; Kunzova S; Lo Re O; Ahola-Olli A; Heliste J; Gonzalez-Rivas JP; Vinciguerra M
    PLoS One; 2023; 18(4):e0284386. PubMed ID: 37079615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?
    Lopes JL; Harris K; Karow MB; Peterson SE; Kluge ML; Kotzer KE; Lopes GS; Larson NB; Bielinski SJ; Scherer SE; Wang L; Weinshilboum RM; Black JL; Moyer AM
    J Mol Diagn; 2022 Mar; 24(3):253-261. PubMed ID: 35041929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United States.
    Stevenson JM; Alexander GC; Palamuttam N; Mehta HB
    Clin Transl Sci; 2021 Jan; 14(1):153-162. PubMed ID: 33085221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
    Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
    Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
    Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
    Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of
    Scherf-Clavel M; Weber H; Unterecker S; Müller DJ; Deckert J
    World J Biol Psychiatry; 2024 Apr; 25(4):214-221. PubMed ID: 38493365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
    Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping Panel.
    Langaee T; El Rouby N; Stauffer L; Galloway C; Cavallari LH
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):209-214. PubMed ID: 30758238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.